How's your portfolio doing? Mine is downSOS!!!
Tech stocks led the $Nasdaq Composite Index (.IXIC.US)$lower 2.83% yesterday with $Meta Platforms (FB.US)$, $Microsoft (MSFT.US)$and $Alphabet-A (GOOGL.US)$losing more than 3%. $Amazon (AMZN.US)$fell more than 2%. I guess the tech sector has to bleed as bond yields surge.
I saw oil&gas gaining. $Schlumberger (SLB.US)$gained 2.4% yesterday.
Do you think it's time to buy the dip in tech or buy oil&gas instead? Why?
Rewards calling! Comment to win rewards!
Moomoo news team likes what I'm posting every day and we hold events together now. You can comment below to win reward points!

BNPL (Buy Now Pay Later）is growing in popularity globally. On Sep 9, $Affirm Holdings (AFRM.US)$ , leading BNPL company, released its Q4 FY21 earnings thatbeats the estimates, following a surge of 20% in stock price during post-market.
Let's take a quick look at some key takeaways.
Operating Highlights
GMV ( Gross merchandise volume) for Q4 FY21 was $2.5 billion, an increase of106%; GMV for fiscal year 2021 was $8.3 billion, an increase of79%.
Active merchants grew by412%to nearly 29,000; Active consumers grew97%to 7.1 million.
Transactions per active consumer increased8%to approximately 2.3.
Financial Highlights
Total revenue was $261.8 million, a71%increase, driven by increases in network revenue and interest income.
Net loss for the Q4 2021 was $128.2 million compared to net income of $34.8 million in Q4 2020.
Business Highlights
In August 2021, the Company announced a non-exclusive partnership with $Affirm Holdings (AFRM.US)$to offer Affirm's flexible payment solutions, and Amazon plans to make Affirm morebroadly availableto its customers.
In June 2021, the Company advanced itsexclusive partnershipwith $Shopify (SHOP.US)$ by making Affirm's Shop Pay Installments available to all eligible Shopify merchants in the US.
Financial Outlook
The company gives apositive outlook. In FY22, Affirm expects GMV to grow faster than revenue. The outlook also reflects its strategy to drivegrowth in its network through continued investment, prioritizing increased investments in both its product and engineering teams, while also increasing its brand and direct response marketing efforts.
These investments are expected to benefit the Company'sproduct innovation capabilities and brand awareness in support of its long-term growth objectives.
Click to see the original report>>
What’s your thoughtson Affirm's Q4 FY21 earnings? Is there any number or move thathits you? Is now a good time to buy or sell?
We can't wait to see your comments.

$aTyr Pharma (LIFE.US)$ cancer trail a success.